A comprehensive view of Endocrine / Hormonal Health. This page highlights a small sample of our full coverage.
For real-time access, please log in to your R&D/Patents Market Intelligence Service.
AstraZeneca acquires French biotech Amolyt Pharma for US$800.0M to expand into rare endocrinology field; deal includes eneboparatide, a Phase 3 candidate drug aimed at potentially reducing dependence on supplements in hypoparathyroidism patients
Published:
March 14, 2024
by FierceBiotech
|
Plastic food packaging contains thousands of hormone-mimicking chemicals that can leach into food, according to new study published in Environmental Science & Technology; researchers found most potent effects from extracts of PU, PVC and LDPE
Published:
March 05, 2024
by CBS - 11 WJHL
|
France fines companies, organizations in the canning sector €19.5M for violating competition rules over use of BPA in packaging, which is claimed to be an endocrine disruptor; companies include Unilever, Bonduelle, General Mills, Ardagh, Crown, Massilly
Published:
January 12, 2024
by CE Noticias Financieras (Latin America)
|
WGSN lists 'hormonal skin care' among big beauty trends for 2024, highlighting links between hormones and acne, impacts of menopause and menstruation; notable brands expanding the category are NAYDAYA, Living M and Faace
Published:
December 20, 2023
by PR Newswire Europe
|
Mount Sinai researchers find testosterone therapy safer than previously thought for transmasculine people; increased red blood cell volume changes are small and unlikely to be clinically significant
Published:
November 27, 2023
by Newswise - Latest News
|
Ask us about our R&D/Patents market view